Ajax Harwood Clinic

Cancer marker (tumour marker) testing: should I be tested?

Last reviewed 2026-09-23Content vffc9adc483c8
Reference tool — not medical advice. Clinician judgement always required.

Tumour markers to check for 'hidden' cancer

Defined testing criteria

Also called: tumour markers, tumor marker panel, cancer blood test, hidden cancer screening, cancer marker panel

Patients ask for CA-125, CA 15-3, CEA, PSA, or a general 'cancer panel' out of a real and understandable fear of a hidden cancer, often after a friend or relative's diagnosis, a Annual bloodwork / wellness panel (executive health screen) recommendation, or online marketing for 'early detection' bloodwork. The fear deserves a straight answer: these tests are poor tools for finding cancer in someone without symptoms, but Ontario does have organized, evidence-based screening programs that are the right answer to 'am I being checked for cancer?'

Raises suspicion

  • • A known pelvic or adnexal mass found on exam or imaging (supports targeted CA-125, not a screening panel)
  • • A personal history of a treated cancer for which the treating oncology team has a monitoring plan
  • • A strong family history of breast, ovarian, or colorectal cancer, or a known hereditary cancer syndrome (e.g., BRCA1/2, Lynch syndrome): this points to a genetics referral and earlier or enhanced organized screening, not a tumour-marker panel
  • • Being due for an organized Ontario screening program (colorectal, breast, cervical, or lung) that has not yet been completed

Does not raise suspicion

  • • Mild, nonspecific fatigue or bloating with no other findings
  • • Wanting 'peace of mind' bloodwork with no symptoms and no risk factors
  • • A normal tumour-marker result being used to justify skipping organized screening that is actually due

Red flags

  • • Unexplained weight loss
  • • Rectal bleeding or a persistent change in bowel habit
  • • A new lump, anywhere
  • • Persistent cough or coughing up blood
  • • Postmenopausal bleeding
  • • Drenching night sweats
  • • Iron-deficiency anemia in a man or a postmenopausal woman with no other explanation

Who to test

  • Asymptomatic adult at average risk, asking for tumour markers for reassurance or as a general screen: CA-125 (Cancer Antigen 125) (Situation-specific), CA 15-3 (Cancer Antigen 15-3) (Situation-specific), CEA (Carcinoembryonic Antigen) (Situation-specific), PSA (Prostate-Specific Antigen), including free PSA and PSA ratio (Situation-specific)Not indicated; the evidence-based path to early detection is Ontario's organized screening programs (ColonCancerCheck/FIT, the Ontario Breast Screening Program, the Ontario Cervical Screening Program (HPV), and the Ontario Lung Screening Program for eligible smokers). See prevention.ajaxharwoodclinic.com to check what each person is due for [1, 2, 3].
  • A known pelvic or adnexal mass on exam or imaging: CA-125 (Cancer Antigen 125) (Situation-specific)Used alongside ultrasound to help triage referral to gynecologic oncology, not as a screening test.
  • A man weighing prostate cancer screening, after a shared decision-making conversation about benefits and harms: PSA (Prostate-Specific Antigen), including free PSA and PSA ratio (Situation-specific)A specific, consent-based screening decision, not a 'hidden cancer' panel; Canadian guidance is mixed ([5] supports shared decision-making from about age 50, or 45 with family history; [4] recommends against screening at every age reviewed).
  • A known, treated malignancy under active oncology follow-upSurveillance testing (CA-125, CA 15-3, CEA, PSA, or others as relevant) is directed by the treating oncology team on a structured schedule, not ordered by the family doctor as a standalone 'check for recurrence' panel [1].
  • Strong family history of breast, ovarian, or colorectal cancer, or a known hereditary cancer syndromeGenetics referral; may also qualify for the High Risk Ontario Breast Screening Program or earlier colonoscopy surveillance (no TestSelect entry for genetic counselling or testing).
  • Any red-flag symptom present: Complete blood count (CBC) (Situation-specific)CBC to check for iron-deficiency anemia; the specific red flag drives further work-up (colonoscopy, imaging, biopsy), not a tumour-marker panel.

More likely instead

  • • health anxiety after a relative's cancer diagnosis
  • • a benign explanation for the specific symptom (e.g., hemorrhoids for rectal bleeding, fibrocystic change for a breast lump) that still needs its own assessment
  • • being overdue for organized screening rather than needing a novel blood test
  • • Why am I tired? (fatigue worked up on its own merits first)

Counselling script

“Tumour markers like CA-125 or CEA aren't good screening tests in someone without symptoms or a known cancer; they miss cancers and flag false alarms in people who don't have one. If you're not up to date on colon, breast, cervical, or lung cancer screening, that's the evidence-based way to check, and we can sort out what you're due for. If you have a specific red-flag symptom, like unexplained weight loss or a new lump, that needs its own direct work-up rather than a blood panel.”

Chart snippet (OSCAR-safe plain text)

Concern discussed, not tested

Concern re: tumour markers / hidden cancer discussed, raised by patient or ND.
Discriminating features: known mass, personal cancer history, strong family history or hereditary syndrome, red-flag symptoms; reviewed and absent.
Assessment: no indication for tumour-marker testing as a general cancer screen.
Plan: organized Ontario screening status reviewed; no tumour markers ordered.
Ref: Choosing Wisely Canada oncology and obstetrics-gynaecology recommendations; USPSTF ovarian cancer screening statement 2018.
Patient given info page: https://cancer-markers.ajaxharwoodclinic.com/patient
Revisit if: a red-flag symptom develops, or organized screening is found to be overdue.

Testing ordered

Concern re: tumour markers / hidden cancer discussed.
Discriminating features: known pelvic mass, personal cancer history under active follow-up, or red-flag symptom present.
Assessment: targeted testing indicated, not a general screening panel.
Plan: test ordered per specific indication noted in the chart; organized Ontario screening status reviewed.
Ref: Choosing Wisely Canada oncology recommendations 2025; Ontario ColonCancerCheck and Breast Screening Program pages.
Patient given info page: https://cancer-markers.ajaxharwoodclinic.com/patient
Revisit if: results are abnormal, or new red-flag symptoms develop.

Revisit if

  • • A red-flag symptom develops or persists
  • • Organized screening (colorectal, breast, cervical, lung) is found to be overdue
  • • A new family history of cancer or a hereditary cancer syndrome comes to light

References

  1. 1. Canadian medical oncology societies / Choosing Wisely Canada. Oncology recommendations (2025)Recommendation against ordering tests to detect recurrent cancer in asymptomatic patients without a realistic expectation of improved survival
  2. 2. Society of Obstetricians and Gynaecologists of Canada / Choosing Wisely Canada. Obstetrics and Gynaecology recommendations (2021)Recommendation against screening for ovarian cancer with CA-125 in asymptomatic average-risk women
  3. 3. US Preventive Services Task Force. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement (2018)USPSTF recommends against ovarian cancer screening in asymptomatic women; screening does not reduce mortality and causes harm
  4. 4. Canadian Task Force on Preventive Health Care. Recommendations on screening for prostate cancer with the prostate-specific antigen test (2014)— older guidelineCTFPHC recommends against PSA screening at every age group it reviewed
  5. 5. Canadian Urological Association. UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis (2022)CUA supports shared decision-making PSA screening from about age 50 (45 with increased risk) after discussing benefits and harms
  6. 6. Ontario Health / Ontario.ca. Colon cancer testing and prevention (ColonCancerCheck) (2026)Ontario's organized average-risk colorectal screening is FIT every 2 years starting at age 45
  7. 7. Ontario Health / Ontario.ca. Breast cancer testing and prevention (Ontario Breast Screening Program) (2024)Ontario Breast Screening Program offers a mammogram every 2 years from age 50, with self-referral from age 40
Evidence notes

Tag rationale: A, not borderline in the sense the batch specified, though this record works differently from a typical A page: the defined, evidence-based answer to 'should I have tumour markers to check for cancer?' is 'no, not as a screen' [1, 2, 3], with organized Ontario screening programs as the defined-criteria answer instead. This record agrees with, and does not duplicate, the individual test records (CA-125 (Cancer Antigen 125), CA 15-3 (Cancer Antigen 15-3), cea, psa), which already carry the detailed indicated/not-indicated criteria and Ontario coverage status for each marker; this page's job is the framing question. The ColonCancerCheck and Ontario Breast Screening Program facts were independently fetched and verified this session [6, 7]. The Ontario Cervical Screening Program (HPV since March 2025) and the Ontario Lung Screening Program are mentioned by name only, since the ahc-testselect 'prevention' app (prevention.ajaxharwoodclinic.com) already carries independently verified, dated facts for all four programs (see its research/sources.md); this session did not re-fetch those two program pages, so no new source id was created for them, and the page should link to prevention for the current, full picture rather than restate unverified specifics. PSA guidance is genuinely mixed between Canadian bodies (CUA 2022 is more favourable to shared decision-making than CTFPHC 2014); both are cited so the physician can weigh them, consistent with how the celiac/NCGS batch handled conflicting guidance.

General clinical reference for Ajax Harwood Clinic. Not medical advice, and not a substitute for individualized clinical assessment.